Neurodevelopmental Disorders: Difference between revisions
From Proteopedia
Jump to navigationJump to search
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
The | [[Image:|350px|right|thumb|The Progression of Cancer]] | ||
[[Neurodevelopmental Disorders]] are | |||
Articles in Proteopedia concerning [[Neurodevelopmental Disorders]] include: | |||
[[Beta-2 Adrenergic Receptor]] - Involved in Autism <br/> | [[Beta-2 Adrenergic Receptor]] - Involved in Autism <br/> | ||
[[Ephrin Type-A Receptor]] - Involved in Tuberous Sclerosis <br/> | [[Ephrin Type-A Receptor]] - Involved in Tuberous Sclerosis <br/> | ||
| Line 10: | Line 13: | ||
[[Serotonin Transporter]] - Involved in OCD and Autism <br/> | [[Serotonin Transporter]] - Involved in OCD and Autism <br/> | ||
[[Shank Family Proteins]] - Involved in 22q13 Deletion Syndrome <br/> | [[Shank Family Proteins]] - Involved in 22q13 Deletion Syndrome <br/> | ||
<br /> | |||
To view [[Neurodevelopmental Disorders]] related proteins which are [[Proteopedia:Structure Index|Structure Index]] entries see: | |||
*<br /> | |||
To view automatically seeded indices concerning [[Neurodevelopmental Disorders]] See: | |||
*[[:Category:Anti-cancer|Anti-Cancer]] | |||
<br /> | |||
To View FDA Approved Treatments for [[Neurodevelopmental Disorders]] See: [[Pharmaceutical_Drugs#Treatments|Treatments]] | |||
To view other Proteopedia pages about diseases & drug targets, See: [[Pharmaceutical_Drug_Targets|Pharmaceutical Drug Targets]] | |||
